Gilead Accusers Say Supreme Court Has Changed the Game on Licensing
Durie Tangri's Mark Lemley, an attorney for a would-be class of consumers and insurers, says a 2015 ruling on a Spider-Man toy established limits on royalties that drug companies are ignoring.
May 16, 2019 at 03:54 PM
5 minute read
The original version of this story was published on The Recorder
If HIV patients and their insurers can win a court ruling that leads to lower drug prices, they might have Spider-Man to thank.
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Trending Stories
- 1The Law Firm Disrupted: For Big Law Names, Shorter is Sweeter
- 2Wine, Dine and Grind (Through the Weekend): Summer Associates Thirst For Experience in 'Real Matters'
- 3The 'Biden Effect' on Senior Attorneys: Should I Stay or Should I Go?
- 4'That's Disappointing': Only 11% of MDL Appointments Went to Attorneys of Color in 2023
- 5'You Are Not Alone': 120 Sex Assault Victims Plan to Sue Sean 'Diddy' Combs
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250
